| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | China | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Canada | 2 | |
| #5 | Taiwan | 2 | |
| #6 | Australia | 1 | |
| #7 | Japan | 1 | |
| #8 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zhang Jie | 12 |
| #2 | Sliskovic D Robert | 12 |
| #3 | Ducker Charles E | 12 |
| #4 | Hamm Stefan | 4 |
| #5 | Eldridge John H | 4 |
| #6 | Clarke David K | 4 |
| #7 | Matassov Demetrius | 3 |
| #8 | Nowak Rebecca | 3 |
| #9 | Nasar Farooq | 3 |
| #10 | Tesh Robert B | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2014093602A1 | Compositions and methods for treating and preventing hepatitis c virus infection | |
| WO2010148042A1 | Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb) | |
| CN102439000A | Benzamide and naphthamide derivatives inhibiting nuclear factor- kap pa (b) - (nf-kb) | |
| EP2411376A1 | Inhibitors of nf-kb | |
| WO2008103346A1 | Compositions and methods for treating viral infections |